Orbimed Advisors LLC Johnson & Johnson Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $50.9 Million - $61.2 Million	-414,100 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $41.6 Million - $48.9 Million	-341,900 Reduced 45.22%	414,100 $57.2 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $34.7 Million - $38.3 Million	290,700 Added 62.48%	756,000 $91.7 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $86.5 Million - $94.7 Million	-659,100 Reduced 58.62%	465,300 $65 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $146 Million - $152 Million	1,124,400	1,124,400 $146 Million

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.